Analytical Data
-
Gene name
Cd101
- Application
-
Alternative Names
Cd101；EWI101；IGSF2；V7；Immunoglobulin superfamily member 2
-
Species
Mouse
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A8E0Y8
-
Expression Region
22-266aa
-
AA Sequence
REVKIQEGPLYRAEGYPVSIRCTVSGHQGPSTQDFRWSIYLPSAPTKEVQIISTKDAGFSYAVYAQRVQSKEIYIERLQGDSVLLHISKLQMKDAGEYECHTPNTDGKYFGSYSAKTNLTVVPDTLSATMPSQTLSKKEGEPLELTCETTKATVQHTHLSLTWYLMQEGGGSQATEIVSLSKDFVLTPGSSYADRFVAGDVRLDKLGATSFRLSVGKLQPSDQGQVFCEATEWIQDPDETWTLIT
-
Molecular Weight
31.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Cd101 is a novel recombinant protein that has garnered significant attention in recent years due to its potential applications in immunology and therapeutics. Initially identified as a member of the CD (cluster of differentiation) family, Cd101 plays a crucial role in modulating immune responses, particularly in T-cell activation and differentiation. The protein is expressed on various immune cells, suggesting its involvement in critical pathways related to immune regulation and tolerance. Recent studies have indicated that Cd101 may inhibit T cell receptor signaling, leading to reduced activation of T cells, which could have implications for autoimmune diseases and transplant acceptance. Additionally, the use of recombinant technology to produce Cd101 allows for a more efficient and standardized method to study its structure-function relationships and biological activities. Researchers are exploring the potential of Cd101 as a therapeutic target, particularly in conditions where immune modulation is needed, such as cancer immunotherapy and chronic inflammatory diseases. As a result, the comprehensive investigation of Cd101 not only enhances our understanding of immune regulation but also opens new avenues for the development of targeted therapies that harness the body's immune system effectively.
